SCHEMBL20005835

SCHEMBL20005835

Cc1cccc(OCCOc2ccc(Cl)cc2C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.52
PPARG P37231 1/20 0.52
PPARD Q03181 1/20 0.52
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.48
ALOX15 P16050 1/20 0.48
KMT2A Q03164 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
ATM Q13315 1/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
SCN4A P35499 1/20 0.46
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283280 0.87 KMT2A (0.57) L3MBTL1KDM4EKMT2ATDP1MEN1
SCHEMBL15869672 0.86 SCN4A (0.56) PPARGPPARDKDM4ETP53ALOX15
SCHEMBL20005627 0.83 DRD2 (0.55) L3MBTL1PPARGPPARDKDM4EKMT2A
SCHEMBL5289703 0.82 DRD2 (0.58) L3MBTL1KDM4EKMT2ATDP1MEN1
SCHEMBL12110823 0.81 ALDH1A1 (0.58) L3MBTL1KDM4EKMT2ATDP1NPC1
SCHEMBL29381067 0.80 DRD2 (0.62) L3MBTL1KDM4EKMT2ATDP1POLB
SCHEMBL27465 0.80 DRD2 (0.62) L3MBTL1KDM4EKMT2ATDP1POLB
SCHEMBL20005629 0.79 SCN4A (0.55) L3MBTL1KDM4ETP53ALOX15KMT2A
SCHEMBL22135588 0.78 KDM4E (0.64) KDM4ETP53ALOX15KMT2AMEN1
SCHEMBL5280785 0.78 L3MBTL1 (0.61) L3MBTL1KMT2ATDP1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 L3MBTL1 805/4885PPARG 860/4885PPARD 945/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 L3MBTL1 805/4885PPARG 860/4885PPARD 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.